33 search results
Medicine-Pulmonology
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
Location: Manchester
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Location: Manchester
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults with Cystic Fibrosis
Location: Manchester
A Phase 2 Study of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 in Subjects with Cystic Fibrosis who are Heterozygous for the F508del Mutation
Location: Manchester
A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
Location: Manchester
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Location: Manchester
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Location: Manchester
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation
Location: Manchester
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Location: Manchester
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
Location: Manchester
A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects with Cystic Fibrosis of Chronic Pancreatitis Treated with Creon (Pancrelipase) with an Alternate Source of Active Pharmaceutical Ingredient
Location: Manchester
Alveolar Macrophage and Peripheral Blood Monocyte Dysfunction in Cystic Fibrosis
Location: Lebanon
An Observational Long-Term Safety Surveillance of Participants from Corbus Sponsored Lenabasum Pivotal Clinical Trials
Location: Manchester
Barriers to Palliative Care Referrals for Pulmonary Hypertension Patients
Location: Lebanon
Biofilm Formation, Antibiotic Resistance Phosphatidylcholine Utilization By Pseudomonas In Cf Sputum
Location: Lebanon, Manchester
COPD and Rural Health: Identifying Environmental Exposures Associated with Adverse Outcomes
Location: Lebanon
CliNIcal Utility of ManaGement of Patients witH CT and LDCT Identified
Pulmonary Nodules UsinG the Percepta NasAL Swab ClassifiEr
(NIGHTINGALE) -with Familiarization
Location: Lebanon
Cystic Fibrosis Foundation Patient Registry
Location: Lebanon, Bedford, Manchester
Evaluation of Autoimmunity in Patients with Non-CF Bronchiectasis
Location: Lebanon
Host Pathogen Interactions in GI Epithelium in Cystic Fibrosis
Location: Lebanon
Influences of temperature and humidity on CF outcomes including frequency of exacerbations and health care encounters
Location: Lebanon
Life after the ICU: Understanding patient needs and experiences
Location: Lebanon
Longitudinal Evaluation of Aspergillus Fumigatus in Patients with Cystic Fibrosis
Location: Lebanon
Lung Abscess and Complicated Pneumonia Database
Location: Lebanon
Mechanical Ventilation Simulation
Location: Lebanon
PHINDER: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection
Location: Lebanon
Perceptions and attitudes of patients at an academic pulmonary practice regarding implementation of Tele-Health clinic visits in a rural setting.
Location: Lebanon
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Location: Lebanon, Manchester
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Location: Lebanon, Manchester
Standardizing Treatments for Pulmonary Exacerbations: A Platform for evaluating treatment decisions to improve outcomes
Location: Lebanon
The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes
Location: Lebanon, Manchester
The Effects Of Systemic Anti-Pseudomonal Therapy On Fungal Load In Cystic Fibrosis
Location: Bedford
Validation of the coopeRATE Measure
Location: Lebanon
